Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionRhumbline Advisers
Latest Disclosed Ownership110,196 shares
Latest Disclosed Value $ 394,489
Rhumbline Advisers reports 2.84% decrease in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

On May 12, 2026 - Rhumbline Advisers filed a 13F-HR form disclosing ownership of 110,196 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $310,202 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 113,420 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of -2.84% during the quarter. The current value of the position is $268,878 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 110,196 -3,224 -2.84 394 -1.01 0.0003
2026-02-13 2025-12-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 113,420 -7,351 -6.09 398 1.27 0.0003
2025-11-06 2025-09-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 120,771 489 0.41 394 33.67 0.0003
2025-08-12 2025-06-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 120,282 12,644 11.75 295 -59.00 0.0003
2025-05-29 2025-03-31 13F/A-1 ROCKET PHARMACEUTICALS INC COM COM 77313F106 107,638 8,299 8.35 718 -42.55 0.0007
2025-04-08 2025-03-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 107,638 8,299 718 0.0007
2025-05-29 2024-12-31 13F/A-1 ROCKET PHARMACEUTICALS INC COM COM 77313F106 99,339 1,242 1.27 1,249 -31.09 0.0011
2025-01-30 2024-12-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 99,339 1,242 1,249 0.0011
2024-11-12 2024-09-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 98,097 -3,037 -3.00 1,812 -16.81 0.0016
2024-08-01 2024-06-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 101,134 4,958 5.16 2,177 -15.95 0.0020
2024-05-09 2024-03-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 96,176 4,163 4.52 2,591 -6.06 0.0025
2024-02-08 2023-12-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 92,013 4,486 5.13 2,758 53.76 0.0029
2023-11-09 2023-09-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 87,527 3,966 4.75 1,793 8.01 0.0021
2023-08-08 2023-06-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 83,561 -8,661 -9.39 1,660 165,900.00 0.0019
2023-05-11 2023-03-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 92,222 7,030 8.25 2 -99.94 0.0019
2023-02-14 2022-12-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 85,192 14,936 21.26 1,667 48.71 0.0022
2022-11-10 2022-09-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 70,256 3,961 5.97 1,121 22.92 0.0017
2022-08-11 2022-06-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 66,295 21,643 48.47 912 28.81 0.0013
2022-05-12 2022-03-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 44,652 1,575 3.66 708 -24.68 0.0009
2022-02-10 2021-12-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 43,077 -1,319 -2.97 940 -29.16 0.0012
2021-11-12 2021-09-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 44,396 1,712 4.01 1,327 -29.79 0.0018
2021-08-05 2021-06-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 42,684 -255 -0.59 1,890 -0.79 0.0025
2021-05-06 2021-03-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 42,939 -3,001 -6.53 1,905 -24.37 0.0026
2021-02-10 2020-12-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 45,940 407 0.89 2,519 141.98 0.0035
2020-11-12 2020-09-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 45,533 -5,950 -11.56 1,041 -3.43 0.0016
2020-08-13 2020-06-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 51,483 12,041 30.53 1,078 96.00 0.0018
2020-05-06 2020-03-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 39,442 1,949 5.20 550 -35.52 0.0012
2020-02-05 2019-12-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 37,493 670 1.82 853 98.83 0.0014
2019-10-23 2019-09-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 36,823 -140 -0.38 429 -22.56 0.0008
2019-08-14 2019-06-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 36,963 6,268 20.42 554 2.97 0.0010
2019-05-01 2019-03-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 30,695 2,573 9.15 538 29.02 0.0010
2019-01-31 2018-12-31 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 28,122 9,036 47.34 417 -11.28 0.0009
2018-11-07 2018-09-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 19,086 -1,201 -5.92 470 18.09 0.0009
2018-08-06 2018-06-30 13F ROCKET PHARMACEUTICALS INC COM COM 77313F106 20,287 20,287 398 0.0008
2017-08-02 2017-06-30 13F INOTEK PHARMACEUTICALS CORP COM 45780V102 0 -29,825 -100.00 0 -100.00
2017-05-02 2017-03-31 13F INOTEK PHARMACEUTICALS CORP COM 45780V102 29,825 12,001 67.33 60 -44.95 0.0001
2017-01-27 2016-12-31 13F INOTEK PHARMACEUTICALS CORP COM 45780V102 17,824 -1,582 -8.15 109 -40.76 0.0003
2016-11-08 2016-09-30 13F INOTEK PHARMACEUTICALS CORP COM 45780V102 19,406 1,400 7.78 184 37.31 0.0005
2016-08-11 2016-06-30 13F INOTEK PHARMACEUTICALS CORP COM 45780V102 18,006 18,006 134 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.